Lv61
2650 积分 2024-05-16 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
5天前
已完结
2023 ACR/EULAR antiphospholipid syndrome classification criteria
14天前
已完结
Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis
22天前
已完结
The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
23天前
已完结
High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis
23天前
已完结
Anti-C1q antibodies in systemic lupus erythematosus
23天前
已完结
The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy
24天前
已完结
Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis
24天前
已完结
Lupus nephritis
27天前
已完结
Intertwined pathways of complement activation command the pathogenesis of lupus nephritis
27天前
已完结
皖公网安备34019202002308
